Stem cell therapy for cerebral palsy: Proceeding with caution
- PMID: 35822233
- DOI: 10.1111/dmcn.15344
Stem cell therapy for cerebral palsy: Proceeding with caution
Comment on
-
Motor function and safety after allogeneic cord blood and cord tissue-derived mesenchymal stromal cells in cerebral palsy: An open-label, randomized trial.Dev Med Child Neurol. 2022 Dec;64(12):1477-1486. doi: 10.1111/dmcn.15325. Epub 2022 Jul 10. Dev Med Child Neurol. 2022. PMID: 35811372 Free PMC article. Clinical Trial.
References
REFERENCES
-
- Basu AP, Clowry G. Improving outcomes in cerebral palsy with early intervention: new translational approaches. Front Neurol 2015; 6: 24.
-
- Dabrowska S, Andrzejewska A, Lukomska B, Janowski M. Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles. J Neuroinflammation 2019; 16: 178.
-
- Eggenberger S, Boucard C, Schoeberlein A, et al. Stem cell treatment and cerebral palsy: Systematic review and meta-analysis. World J Stem Cells 2019; 11: 891-903.
-
- Sun JM, Case LE, Mclaughlin C, et al. Motor function and safety after allogeneic cord blood and cord tissue-derived mesenchymal stromal cells in cerebral palsy: an open label, randomized trial. Dev Med Child Neurol 2022.
-
- Sun JM, Song AW, Case LE, et al. Effect of Autologous Cord Blood Infusion on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy: A Randomized, Placebo-Controlled Trial. Stem Cells Transl Med 2017; 6: 2071-8.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
